Eserolein, Methylcarbamate

Eserolein, Methylcarbamate Brand names, Eserolein, Methylcarbamate Analogs

Eserolein, Methylcarbamate Brand Names Mixture

No information avaliable

Eserolein, Methylcarbamate Chemical_Formula

C₁₅H₂₁N₃O₂

Eserolein, Methylcarbamate RX_link

http://www.rxlist.com/cgi/generic3/physostigmine.htm

Eserolein, Methylcarbamate fda sheet

Eserolein, Methylcarbamate msds (material safety sheet)

Eserolein, Methylcarbamate Synthesis Reference

Zhang J,et al. Appl Microbiol Biotechnol. 44(5):568-75.

Eserolein, Methylcarbamate Molecular Weight

275.346 g/mol

Eserolein, Methylcarbamate Melting Point

105.5 ^oC

Eserolein, Methylcarbamate H₂O Solubility

7760 mg/L

Eserolein, Methylcarbamate State

Solid

Eserolein, Methylcarbamate LogP

1.582

Eserolein, Methylcarbamate Dosage Forms

Liquid

Eserolein, Methylcarbamate Indication

For the treatment of glaucoma, and in the treatment of severe anticholinergic toxicity.

Eserolein, Methylcarbamate Pharmacology

Physostigmine is a parasympathomimetic, specifically, a reversible cholinesterase inhibitor which effectively increases the concentration of acetylcholine at the sites of cholinergic transmission. Physostigmine is used to treat glaucoma. Because it crosses the blood-brain barrier, it is also used to treat the central nervous system effects of atropine overdose and other anticholinergic drug overdoses. Physostigmine can reverse both central and peripheral anticholinergia.

Eserolein, Methylcarbamate Absorption

No information avaliable

Eserolein, Methylcarbamate side effects and Toxicity

Side effects include increased sweating, loss of bladder control, muscle weakness, nausea, vomiting, diarrhea, or stomach cramps or pain, shortness of breath, tightness in chest, or wheezing, slow or irregular heartbeat, unusual tiredness or weakness, watering of mouth, blurred vision or change in near or distant vision, and eye pain.

Eserolein, Methylcarbamate Patient Information